Author:
Ratain Mark J.,Humphrey Rachel W.,Gordon Gary B.,Fyfe Gwen,Adamson Peter C.,Fleming Thomas R.,Stadler Walter M.,Berry Donald A.,Peck Carl C.
Reference32 articles.
1. Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties;Michaelis;Clin Cancer Res,2007
2. Phase II oncology trials: let’s be positive;Ratain;Clin Cancer Res,2005
3. Can the pharmaceutical industry reduce attrition rates?;Kola;Nat Rev Drug Discov,2004
4. European Medicines Agency. ICH Topic E 4: Dose response information to support drug registration. Canary Wharf, London; 1994.
5. FDA. Guidance for industry: Exposure-response relationships - Study design, data analysis, and regulatory applications. Rockville, MD; 2003.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献